Among 1,847 Bahamian women who had never had breast or ovarian cancer, 2.8% of those with a family history of these cancers carried a founder BRCA mutation, against 0.09% of those without one.
The study asked whether testing the whole population for BRCA mutations is worthwhile in the Bahamas, where 23% of women with breast cancer carry one of seven founder mutations in BRCA1 or BRCA2. It tested 1,847 women with no personal history of breast or ovarian cancer, unselected for age or family history. The authors had earlier suggested that all Bahamian women with breast or ovarian cancer be offered genetic testing, and conclude that all unaffected Bahamian women with a family history of breast or ovarian cancer should be offered it as well.
For a Bahamian woman who has not had cancer, a family history of breast or ovarian cancer is what makes a founder-mutation test likely to find something.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/